IP Library Granted Patent US 7,996,170
Granted Patent B2
US 7,996,170 · App. 12/466,135 · Granted Aug 9, 2011

System and method for sorting data

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,996,170
App. No.
12/466,135
Granted
Aug 9, 2011
Kind
B2
Abstract

A method and apparatus that enables a user to sort data from one or more sample lots, which may be obtained via a network, such as the Internet, into a composite parameter structure. The composite parameter structure is a function of one or more parameters corresponding to one or more characteristics associated with one or more sample lots. The composite parameter structure representation may be printed, stored, or transmitted to another location. A server device that is coupled and working in conjunction with a client device may implement the present invention.

Claims (43)

1. A method for determining whether the chemical composition of a generic formulation corresponds to that of a reference listed drug, comprising:

(a) creating a composite parameter structure corresponding to the reference listed drug by:

(i) providing data related to a first sample lot of the reference listed drug and data related to a second sample lot of the reference listed drug to a processor;

(ii) using the processor to identify one or more characteristics associated with the first sample lot;

(iii) using the processor to identify parameters corresponding to each of the one or more characteristics of the first sample lot;

(iv) using the processor to identify one or more characteristics associated with the second sample lot;

(v) using the processor to determine whether the one or more characteristics associated with the second sample lot correspond to one or more of the parameters corresponding to the characteristic of the first sample lot;

(vi) using the processor to establish one or more additional parameters corresponding to each characteristic of the second sample lot that does not correspond to the parameters corresponding to the characteristic of the first sample lot;

(vii) using the processor to provide the additional parameters to an output device; and

(viii) using the processor to establish the composite parameter structure as a function of the parameters corresponding to characteristics of the first sample lot and the additional parameters;

(b) comparing data related to at least one sample lot of the generic formulation to the composite parameter structure; and

(c) determining whether the chemical composition of the generic formulation corresponds to that of the reference listed drug based on the comparison in step (b).

2. The method of claim 1 , wherein at least one of the characteristics is a function of a relative retention time.

3. The method of claim 1 , wherein at least one of the characteristics is a function of atomic mass units.

4. The method of claim 1 , wherein at least one of the characteristics is a function of one or more peaks.

5. The method of claim 4 , wherein each peak is a function of a relative retention time.

6. The method of claim 1 , wherein the reference listed drug comprises a biological material.

7. The method of claim 6 , wherein the biological material is a conjugated estrogen.

8. A processing apparatus comprising:

(a) at least one memory; and

(b) a processor coupled to the memory, wherein the processor is adapted to execute program code to:

identify one or more characteristics associated with the first sample lot;

identify parameters corresponding to each of the one or more characteristics of the first sample lot;

identify one or more characteristics associated with the second sample lot;

determine whether the one or more characteristics associated with the second sample lot correspond to one or more of the parameters corresponding to the characteristic of the first sample lot;

establish one or more additional parameters corresponding to each characteristic of the second sample lot that does not correspond to the parameters corresponding to the characteristic of the first sample lot;

provide the additional parameters to an output device; and

establish a composite parameter structure as a function of the parameters corresponding to characteristics of the first sample lot and the additional parameters.

9. The processing apparatus of claim 8 , wherein the processor is further adapted to execute program code to generate a representation as a function of the first sample lot, the characteristics of the second sample lot, and the composite parameter structure.

10. The processing apparatus of claim 8 , wherein the processor is further adapted to execute program code to modify one or more boundaries of the composite parameter structure as a function of the one or more characteristics associated with the first sample lot and the second sample lot.

11. The processing apparatus of claim 10 , wherein the one or more boundaries are a function of a predetermined mathematical relationship.

12. The processing apparatus of claim 8 , wherein the processor is further adapted to execute program code to:

identify one or more characteristics associated with a third sample lot; and

determine whether the one or more characteristics associated with the third sample lot correspond to one or more parameters of the composite parameter structure.

13. The processing apparatus of claim 12 , wherein the processor is further adapted to execute program code to modify the composite parameter structure as a function of characteristics of the third sample lot.

14. The processing apparatus of claim 8 , wherein the processor is further adapted to execute program code to:

identify one or more characteristics associated with an n th -sample lot; and

determine whether the one or more characteristics associated with the n th -sample lot correspond to one or more parameters of the composite structure.

15. The processing apparatus of claim 8 , wherein the processor is further adapted to execute program code to assign one or more compounds to selected parameters.

16. The processing apparatus of claim 8 , wherein at least one of the characteristics is a function of a relative retention time.

17. The processing apparatus of claim 8 , wherein at least one of the characteristics is a function of atomic mass units.

18. The processing apparatus of claim 8 , wherein at least one of the characteristics is a function of one or more peaks.

19. The processing apparatus of claim 18 , wherein each peak is a function of a relative retention time.

Assignments (10)
RELEASE OF SECURITY INTEREST Recorded Apr 26, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH HOLDINGS, LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO GENERIC HOLDINGS, INC. (FORMERLY KNOWN AS PAR PHARMACEUTICALS COMPANIES, INC.); ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067240/0001 →
RELEASE OF SECURITY INTEREST Recorded Apr 25, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR PHARMACEUTICAL COMPANIES, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067239/0542 →
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Apr 6, 2021
From: BIOSPECIFICS TECHNOLOGIES LLC; PAR PHARMACEUTICAL, INC.; AUXILIUM US HOLDINGS, LLC; ASTORA WOMEN'S HEALTH, LLC; ENDO PHARMACEUTICALS SOLUTIONS INC.; ENDO PHARMACEUTICALS, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 055846/0246 →
SECURITY INTEREST Recorded Jun 8, 2017
From: PAR PHARMACEUTICAL, INC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE
Reel/Frame 042743/0216 →
RELEASE OF SECURITY INTEREST Recorded Apr 28, 2017
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: PAR PHARMACEUTICAL, INC.; ENDO GENERICS HOLDINGS, INC.; INNOTEQ, INC.
Reel/Frame 042171/0036 →
RELEASE OF SECURITY INTEREST Recorded Sep 30, 2015
From: BANK OF AMERICA, N.A.
To: PAR PHARMACEUTICAL, INC.; INNOTEQ, INC.; PAR PHARMACEUTICAL COMPANIES, INC.
Reel/Frame 036695/0782 →
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Sep 25, 2015
From: PAR PHARMACEUTICAL, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 036687/0821 →
SECURITY AGREEMENT Recorded Oct 1, 2012
From: PAR PHARMACEUTICAL COMPANIES, INC.; PAR PHARMACEUTICAL, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 029061/0252 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 29, 2012
From: FEMIA, ROBERT A.
To: PAR PHARMACEUTICAL, INC.
Reel/Frame 028871/0444 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 29, 2012
From: RUEMER, ROBERT; RAGUNATHAN, NARAYAN
To: PAR PHARMACEUTICAL, INC.
Reel/Frame 028871/0363 →